Search results
New mRNA cancer vaccine triggers fierce immune response to fight malignant brain tumor
Medical Xpress· 24 hours agoReported May 1 in the journal Cell, the discovery represents a potential new way to recruit the...
Moderna Puts Up Big Quarterly Beat; Could Shares Break Out?
Investor's Business Daily· 4 hours agoModerna (MRNA) beat Wall Street's first-quarter expectations Thursday. The Covid vaccine maker came...
TIME100 Health: Barney Graham
Time via AOL· 2 hours agoUndeterred, Graham realized that he could adapt what he had discovered from RSV to the new virus, SARS-CoV-2. The rest is vaccine history: Graham’s work...
Brain cancer in children is notoriously hard to treat – a new mRNA cancer vaccine triggers an attack...
The Conversation via Yahoo News· 23 hours agoCancer vaccines have gained much interest among scientists but face a number of hurdles. A new mRNA ...
mRNA Brain Cancer Vaccine Shows Promise In Early Trials In Humans – And Dogs
IFLScience· 24 hours agoA new mRNA vaccine candidate for aggressive brain cancer has shown promise in a small clinical trial...
Flu vs COVID: Stark Disparity in Vaccination and Deaths
Medscape· 10 hours agoIn the first half of 2023, COVID-19 killed 42,670 people in the United States, while the flu killed...
Moderna Inc (MRNA) Q1 2024 Earnings: Significant Revenue Decline
Guru Focus· 8 hours agoOn May 2, 2024, Moderna Inc (MRNA, Financial) released its 8-K filing, disclosing a challenging first quarter with total revenues of $167 million, a stark decline from $1.9 ...
Moderna Q1 earnings: lower-than-expected loss of $1.18 billion sets tone for vaccine launch | Invezz
Invezz· 4 hours agoModerna Inc (NASDAQ: MRNA) reported a narrower-than-expected loss for the first quarter of the year,...
Promising results for an mRNA vaccine against the most aggressive brain cancer
Hardwood Paroxysm· 7 hours agoFour adult patients with glioblastoma, the most aggressive and deadly brain tumor, were able to live up to 50% longer than expected thanks to… Experimental mRNA vaccine ...
TIME100 Health: Katalin Kariko and Drew Weissman
Time Magazine· 2 hours agoDr. Drew Weissman was working on developing an HIV vaccine, and Katalin Kariko was struggling to keep her lab open and convince her superiors that her...
